Microvascular invasion as a predictor of disease progression in prostate cancer.

被引：0
|
作者：
Herman, CM [1 ]
Wilcox, GE [1 ]
Kattan, MW [1 ]
Scardino, PT [1 ]
Wheeler, TM [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
MODERN PATHOLOGY | 1998年 / 11卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：84A / 84A
页数：1
相关论文
共 50 条
  • [21] Red Cell Distribution Width as a Predictor of Prostate Cancer Progression
    Albayrak, Sebahattin
    Zengin, Kursad
    Tanik, Serhat
    Bakirtas, Hasan
    Imamoglu, Abdurrahim
    Gurdal, Mesut
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (18) : 7781 - 7784
  • [22] Maturation of cathepsin D as possible predictor of prostate cancer progression
    Mordente, JA
    Cherry, JP
    Chapman, J
    Choudhury, MS
    Tazaki, H
    Mallouh, C
    Konno, S
    MOLECULAR UROLOGY, 1998, 2 (01) : 1 - 5
  • [23] Possible roles of CDC6 in the progression of prostate cancer.
    Robles, LD
    Ramos, R
    Davila, M
    Chakrabarti, R
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 241A - 241A
  • [24] Chemo-hormonal therapy for biochemical progression of prostate cancer.
    Taplin, M.
    Xie, W.
    Morganstern, D.
    Bubley, G.
    Ernstoff, M.
    Regan, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 231S - 231S
  • [25] Microvascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer
    Borretzen, Astrid
    Reisaeter, Lars A. R.
    Ringheim, Anders
    Gravdal, Karsten
    Haukaas, Svein A.
    Fasmer, Kristine E.
    Haldorsen, Ingfrid H. S.
    Beisland, Christian
    Akslen, Lars A.
    Halvorsen, Ole J.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [26] Microvascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer
    Astrid Børretzen
    Lars A. R. Reisæter
    Anders Ringheim
    Karsten Gravdal
    Svein A. Haukaas
    Kristine E. Fasmer
    Ingfrid H. S. Haldorsen
    Christian Beisland
    Lars A. Akslen
    Ole J. Halvorsen
    Scientific Reports, 13
  • [27] P53 as a predictor of clinical outcome in localized prostate cancer.
    Mahon, Kate Lynette
    Stricker, Phillip
    Kench, James
    Grogan, Judith
    Delprado, Warick
    Turner, Jenny
    Horvath, Lisa
    Quinn, David I.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [28] RIPK2 as a prognostic biomarker and predictor of aggressive prostate cancer.
    Hammudi, Mustafa
    Aldhahri, Walaa
    Kalola, Akshar
    McCullum, Catherine
    Motoni, Caddie
    Martha, Antonio
    Rajendran, Rithika
    Nava, Victor
    Estephan, Fayez
    Byrne, Morgan
    Diao, Guoqing
    Jain, Maneesh Rajiv
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [29] Inflammatory bowel disease and the risk of prostate cancer.
    Kundu, Shilajit
    Burns, Jacob A.
    Weiner, Adam Benjamin
    Catalona, William
    Schaeffer, Edward M.
    Vashi, Ronak
    Li, Eric
    Hanauer, Stephen
    Strong, Scott
    Burns, James
    Hussain, Maha
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [30] ODAM is a predictor for biomedical recurrence and inhibits the migration and invasion of prostate cancer
    Luo, Yun
    Wu, Jie-Ying
    Hou, Guo-Liang
    Lu, Min-Hua
    Shi, Zhi
    Di, Jin-Ming
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (02): : 670 - 679
12345